Increased Expression of TSH Receptor by Fibrocytes in Thyroid-Associated Ophthalmopathy Leads to Chemokine Production
Author(s) -
Erin F. Gillespie,
K. Papageorgiou,
Roshini Fernando,
Nupur Raychaudhuri,
Kimberly Cockerham,
Laya K. Charara,
Allan Christian Pieroni Gonçalves,
Shuang-Xia Zhao,
Anna Ginter,
Ying Lu,
Terry J. Smith,
Raymond S. Douglas
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-2514
Subject(s) - fibrocyte , medicine , chemokine , peripheral blood mononuclear cell , flow cytometry , immunology , cd14 , graves' disease , receptor , thyroid , pathology , endocrinology , biology , biochemistry , in vitro
The molecular basis for anatomically dispersed clinical manifestations in Graves' disease (GD) eludes our understanding. Bone marrow-derived, pluripotent fibrocytes represent a subset of peripheral blood mononuclear cells and infiltrate the orbital and thyroid tissues in GD. These cells may be involved in the pathogenesis of thyroid-associated ophthalmopathy (TAO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom